Full-Time
Job Not Found
Gentell
51-200 employees
Vertically-integrated wound care product manufacturer
No salary listed
Downey, CA, USA
In Person
Must reside in Southern California; daily travel to facilities with occasional overnights and potential corporate training travel.
 Medical, Clinical & Veterinary (1) |
|---|
- Valid healthcare license (RN, LPN, PT, OTR-L, DPM or similar) preferred but could be certified in the first year of hire
- Must have exemplary customer service skills
- Must be business savvy, sales-minded
- Must be a self-starter and work independently
- Must be hard-working and motivated
- Must be organized and detail-oriented
- Must live in the area designated and be willing to travel on a daily basis
- Working with long-term care facilities in a designated territory to assist with wound assessments and treatment decisions
- Monitoring proper application and utilization of wound care products
- Understanding Medicare documentation and reimbursement guidelines
- Educating facility staff on documentation that meets federal and state requirements
- Ordering wound care products through our internal system “FastCare” for the residents to receive their products
- Supporting facilities wound care programs by assisting with tracking, documentation, and understanding of the wound care products coverage guidelines
Gentell is a vertically integrated wound care company that develops and manufactures a broad range of products for hospitals, nursing homes, hospices and other settings, including traditional and advanced dressings, skin-protection products, and related supplies, with production facilities in the US, Canada and China and clinical specialists across North America. Its products manage moisture, protect wounds, support healing and prevent infection through a mix of materials like hydrogels, foams, collagens, alginates and gauzes. It differentiates itself with end-to-end control via vertical integration and a nationwide network of clinical specialists who guide treatment and educate on proper use. Its goal is to provide effective, affordable wound care solutions and hands-on support to improve patient outcomes across care settings.
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Bristol, Virginia
Founded
1994
Simplify's Take
What believers are saying
- ISG acquisition expands nursing home penetration to 42%, enabling cross-sell of nutrition and wound care.
- Three acquisitions in 12 months consolidate fragmented market and absorb specialized product lines rapidly.
- Nutrition-to-wound-care integration strategy differentiates Gentell by addressing clinical link between nutritional status and healing.
What critics are saying
- Rapid ISG, ManukaMed, Casex integrations risk operational inefficiency and customer retention within 6-12 months.
- FDA regulatory scrutiny on FASTCARE 2.0 AI halts predictive analytics due to HIPAA data privacy violations.
- ConvaTec's established Latin American ostomy network blocks 20% market share gains from Casex acquisition.
What makes Gentell unique
- Vertically integrated five-continent manufacturing eliminates supply chain intermediaries and enables localized production.
- FASTCARE 2.0 AI database with predictive analytics transforms Gentell into software-enabled wound care provider.
- Exclusive Medicare-reimbursable Manuka honey dressings create defensible product category with clinical evidence.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Professional Development Budget
Company News
Gentell, the largest vertically integrated wound care company, has acquired Innovative Supply Group (ISG), a leading Medicare Part B supplier of medical tube devices to North American nursing homes. Financial terms were not disclosed. ISG will operate as Gentell Nutritional Services, with Michael Lebovics, formerly ISG's president, leading the division. Gentell currently serves over 30% of the estimated 15,000 US nursing homes with wound care supplies. The acquisition is expected to expand its market share by approximately 12%. This marks Gentell's third acquisition in 12 months, following purchases of New Zealand-based Manukamed and Paraguay-Brazil manufacturer Casex. The company now operates manufacturing facilities across five continents and has increasingly focused on linking nutrition to wound care for improved healing outcomes.
Gentell, led by CEO David Navazio, has acquired New Zealand-based ManukaMed, a manufacturer of honey-based wound dressings. This acquisition allows Gentell to control the only honey-based wound care product reimbursable by Medicare and other U.S. insurance organizations. ManukaMed's patented medical-grade honey blend is proven effective for healing venous ulcers, pressure ulcers, and chronic wounds.
Gentell, the world's largest vertically integrated wound care company, has expanded its global presence by acquiring Casex, a leading Latin American manufacturer of ostomy and wound care products. Announced by Gentell's President and CEO, David Navazio, on June 5, 2025, the acquisition will see Casex rebranded under the Gentell name, enhancing Gentell's distribution capabilities in Latin America.
Gentell unveils ai-powered Wound Care management system.
Gentell introduces FASTCARE(R) 2.0 - National medical database devoted to Wound Care, with analytical & predictive AI.